» Articles » PMID: 39148063

Association Between Kidney Function and Parkinson's Disease Risk: a Prospective Study from the UK Biobank

Overview
Publisher Biomed Central
Specialty Public Health
Date 2024 Aug 15
PMID 39148063
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Parkinson's disease (PD) is a neurodegenerative influenced by various clinical factors. The potential relationship between renal function and the risk of PD remains poorly understood. This study aims to explore the association between kidney function and the risk of developing PD.

Methods: A population-based cohort study was conducted using data from 400,571 UK Biobank participants. Renal function was assessed using the estimated glomerular filtration rate (eGFR), calculated from serum creatinine and cystatin C levels. The association between eGFR levels and PD risk was evaluated using univariate and multivariate Cox regression analyses, Restricted Cubic Spline (RCS) analysis, and Kaplan-Meier analysis. Additionally, a clinical prediction model was developed and its diagnostic accuracy was evaluated using ROC analysis. A heatmap was also constructed to examine the relationship between clinical factors and gray matter volume in various brain regions.

Results: Over a median observation period of 13.8 years, 2740 PD events were recorded. Cox regression and Kaplan-Meier analyses revealed a significant association between decreased eGFR and increased PD risk, particularly in participants with eGFR < 30 ml/min/1.73 m. This association was confirmed across three adjusted models. RCS analysis demonstrated a nonlinear relationship between decreasing eGFR and increasing PD risk. Furthermore, changes in eGFR were correlated with alterations in subcortical gray matter volume in regions such as the frontal cortex, striatum, and cerebellum. The clinical prediction model showed high diagnostic accuracy with AUC values of 0.776, 0.780, and 0.824 for 4-, 8-, and 16-year predictions, respectively.

Conclusion: Renal insufficiency is significantly associated with an increased risk of PD, highlighting the importance of maintaining good kidney function as a potential preventive measure against PD.

References
1.
Jabbari B, Vaziri N . The nature, consequences, and management of neurological disorders in chronic kidney disease. Hemodial Int. 2017; 22(2):150-160. DOI: 10.1111/hdi.12587. View

2.
Corsonello A, Fabbietti P, Formiga F, Moreno-Gonzalez R, Tap L, Mattace-Raso F . Chronic kidney disease in the context of multimorbidity patterns: the role of physical performance : The screening for CKD among older people across Europe (SCOPE) study. BMC Geriatr. 2020; 20(Suppl 1):350. PMC: 7532089. DOI: 10.1186/s12877-020-01696-4. View

3.
de Donato A, Buonincontri V, Borriello G, Martinelli G, Mone P . The Dopamine System: Insights between Kidney and Brain. Kidney Blood Press Res. 2022; 47(8):493-505. DOI: 10.1159/000522132. View

4.
Belvisi D, Pellicciari R, Fabbrini G, Tinazzi M, Berardelli A, Defazio G . Modifiable risk and protective factors in disease development, progression and clinical subtypes of Parkinson's disease: What do prospective studies suggest?. Neurobiol Dis. 2019; 134:104671. DOI: 10.1016/j.nbd.2019.104671. View

5.
Yan M, Jin H, Pan C, Hang H, Li D, Han X . Movement Disorder and Neurotoxicity Induced by Chronic Exposure to Microcystin-LR in Mice. Mol Neurobiol. 2022; 59(9):5516-5531. DOI: 10.1007/s12035-022-02919-y. View